Effects of Tolvaptan, an Oral Vasopressin V2 Receptor Antagonist, in Hyponatremia
No abstract is available. To read the body of this article, please view the Full Text online.
PII: S0272-6386(07)00940-7
doi:10.1053/j.ajkd.2007.06.011
© 2007 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
